NCT02027584

Brief Summary

To study concentrations of choline, its metabolites, and phospholipids in cord blood and remnants of clinically indicated blood samples

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
414

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2013

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 6, 2014

Completed
Last Updated

January 6, 2014

Status Verified

December 1, 2013

Enrollment Period

4.7 years

First QC Date

December 20, 2013

Last Update Submit

January 2, 2014

Conditions

Keywords

infant, prematureinfant, newborncholine

Outcome Measures

Primary Outcomes (1)

  • Concentration of choline in plasma

    at times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)

Secondary Outcomes (2)

  • concentrations of choline metabolites

    at times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)

  • Concentrations of molecular species of phosphatidylcholine and phosphatidylethanolamine

    at times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)

Study Arms (4)

parturient

mother who had given birth within 48 hours of clinically indicated blood sampling

Other: collection of remnant of clinically indicated blood sample

healthy, non-pregnant, female volunteers

healthy, non-pregnant, female volunteers

Other: collection of remnant of clinically indicated blood sample

preterm infant

gestational age at birth \< 37 weeks

Other: collection of remnant of clinically indicated blood sample

term infant

gestational age at birth \>36 weeks

Other: collection of remnant of clinically indicated blood sample

Interventions

collection of remnant of clinically indicated blood sample

healthy, non-pregnant, female volunteersparturientpreterm infantterm infant

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

term and preterm neonates, parturients, non-pregnant females

You may qualify if:

  • meeting criteria of the 4 cohorts

You may not qualify if:

  • none pre-defined

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Tuebingen

Tübingen, 72076, Germany

Location

Related Publications (2)

  • Bernhard W, Full A, Arand J, Maas C, Poets CF, Franz AR. Choline supply of preterm infants: assessment of dietary intake and pathophysiological considerations. Eur J Nutr. 2013 Apr;52(3):1269-78. doi: 10.1007/s00394-012-0438-x. Epub 2012 Sep 9.

    PMID: 22961562BACKGROUND
  • Bernhard W, Raith M, Kunze R, Koch V, Heni M, Maas C, Abele H, Poets CF, Franz AR. Choline concentrations are lower in postnatal plasma of preterm infants than in cord plasma. Eur J Nutr. 2015 Aug;54(5):733-41. doi: 10.1007/s00394-014-0751-7. Epub 2014 Aug 23.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Wolfgang Bernhard, MD, PhD

    University Hospital Tuebingen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2013

First Posted

January 6, 2014

Study Start

November 1, 2008

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

January 6, 2014

Record last verified: 2013-12

Locations